Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
If 3 of the 4 are SD Biosensor, Healgen & Innova, they are not British, but more importantly are not 'quoted' coys. Could explain the silence re the 4th (Avacta being listed).
Think.....you were really keen yesterday " can see just the opposite happening and Deep Verge buying Avacta in the future,
Looking ahead to next year, Brandon is keen to make an even larger acquisition to bolster its distribution channels.
https://www.yorkshirepost.co.uk/business/life-sciences-chief-who-has-become-covid-water-detective-2976660"
Not sure they update the site that often (except for rns). 2 vacancies have a closing date of 31 Aug, the other 27 July. If the news item you refer to is from the investors page, then it's dated 6 Aug, & plenty since then. So while site revamped certain aspects appear not up to date.
Close $3.92 with 'after hours' showing $3.77. Big trade recorded just before close (15.58) 10,011 shares. Looks a buy.
I'm interested to discover the total 'short' for today. Hopeful that bottom of retrace is behind us (joke in there somewhere) but who knows while 'shorts'/manipulation dictates. However, pretty confident new year will see us much happier.
Whimax re yr earlier post. For info the site I forwarded does also include live trades: https://www.nasdaq.com/market-activity/stocks/tlsa/latest-real-time-trades
Think the problem lies with extent TLSA being shorted. Again, yesterday, just over 20% of total volume https://fintel.io/ss/us/tlsa. This seems to be a long established trend as witnessed https://www.nasdaq.com/market-activity/stocks/tlsa/short-interest. Seems to me this is the reason behind our sp not responding to good news. Might have to wait until the Foralumab news before we can shake off the shorters. Hope not.
Missed link: https://www.nasdaq.com/market-activity/stocks/tlsa/real-time
Lot of stuff on here. Not sure about volumes, but could, on a daily basis, provide trade details (similar london stock exchange site). 'Short Interest' tab interesting, which shows historic volumes.
Personally, comfortable with gentle upward momentum. If the sp grew by only 1% per day from 150p it would be 225p by mid November. I'd be very happy with that going into the promise of the inhaler date in December. Not suit traders, but for those in for a longer journey.........
Interesting that again 'shorts' had 21% of the volume yesterday but the sp continued to climb. Much better we enjoy slow daily increments until end October, hopefully followed by positive inhaler news, which should set this alight.
Currently some 16%. However, surprised at the volume/% of 'short' trades recorded on the Nasdaq yesterday.
https://fintel.io/ss/us/tlsa
Looks to me the 'test' has not yet started, so at least another 2 weeks. He posted "The medical doctor in me is getting a sense of deja-vu again. Also in the news is the lack of COVID-19 testing. The next fortnight is going to be informative..." & then "We have completed site initiation visit for the UK lateral flow antigen testing study as part of #moonshot evaluation. Well run centres. @MFTnhs research nurse Anila is confident it’s unusual but @falcon_study is going to be a success!"
So.."next fortnight ..informative" & site visit for...antigen testing study"
No one on this bb can provide answers, only speculation. So lodge your interest and raise any issues you have:
A shareholder and investor webinar presentation by Alastair Smith, Chief Executive Officer, Tony Gardiner, Chief Financial Officer and Neil Bell, Chief Development Officer will take place at 10:30 hrs on Monday, 28 September 2020.
Maybe another false dawn, but currently +12%
extract from france24 link suggests it's an antibody test "This test is similar in ways to a pregnancy test. The colour of a saliva-soaked tablet will indicate whether or not virus antibodies are present without any need to go to a laboratory for analysis."